Patterns of Care 연구 개발을 위한 직장암의 수술 후 방사선치료 시 적정 방사선치료 조사영역 제안

Suggestion of Optimal Radiation Fields in Rectal Cancer Patients after Surgical Resection for the Development of the Patterns of Care Study

  • 발행 : 2003.09.01

초록

목적: 전국의 각 병원 방사선종양학과 전문의들이 시행하고 있는 직장암의 수술 후 방사선치료 조사영역 결정 원칙들을 취합하여 이를 바탕으로 표준적인 조사영역을 제시하고 향후 Patterns of Care 연구를 위한 기본 자료로 삼고자 한다. 대상 및 방법: 경인지역 소재 18개 병원의 방사선종양학과 전문의들이 모인 합의도출 위원회에서 직장암의 수술 후 방사선치료 조사영역 결정 원칙을 파악하기 위해 개발한 항목들을 이용하여 직장암의 방사선치료를 담당하고 있는 전국의 48개 병원 방사선종양학과 전문의들을 대상으로 설문조사를 시행하였다. 전문의 별 치료원칙의 파악에 사용된 설문 항목들은 모의치료 시 조사영역 결정 19개 항목으로서 전후방 치료 시의 상연, 하연 및 측연과 측면 치료 시 전연, 후연 및 차폐물의 적용 범위 등을 묻는 내용이었고, 45개 병원 중 33개 병원의 전문의들로부터 회신된 내용과 해부학적, 임상적 결과들을 바탕으로 일반적으로 권장할 만한 적절한 방사선조사영역을 도출하였다. 결과: 직장암의 수술 후 방사선치료 조사영역 결정에 있어 권고할 만한 일반적인 원칙으로 다음의 사항들을 개발하였다. 상연은 제5요추 하단이나 중간부위, 또는 천장골관절 상단, 하연은 전하방 절제수술 시에는 문합부로부터 일정거리 하방, 복회음부 절제수술 시는 회음부 봉합부로부터 일정거리 하방, 전후방 치료 시의 측연은 골반강 내벽면으로부터 일정거리 외측, 측면 치료 시의 전연은 치골결합부 후단, 그리고 후연은 천골 전면 또는 후면으로부터 일정거리 후방으로 정하여 천골 전면부의 공간을 충분히 포함시키는 것이 합리적인 것으로 나타났다. 권고안과 비교할 때, 상연의 경우 23건($70\%$), 하연의 경우 전하방절제수술 시 13건($39\%$), 복회음부 절제수술시 32건($97\%$), 측연의 경우 32건($97\%$), 후연의 경우 32건($97\%$), 그리고 전연의 경우 16건($45\%$)에서 부합되는 것으로 나타났다. 결론: 직장암의 수술 후 방사선치료 시 적절한 방사선치료 조사영역의 결정을 위하여 표준적인 조사영역을 제시 하였으나 개별 환자의 병변 위치와 진행상태, 수술 소견 등에 따라 적절한 변형은 필수적이라 하겠다. 이 권고안의 임상적 타당성은 향후 시행될 Patterns of Care 연구를 통하여 증명하는 것이 필요하겠다.

Purpose: To suggest the optimal radiation fields after a surgical resection based on a nationwide survey on the principles of radiotherapy for rectal cancer in the Korean Patterns on Care Study. Materials and method: A consensus committee, composed of radiation oncologists from 18 hospitals in Seoul Metropolitan area, developed a survey format to analyze radiation oncologist's treatment principles for rectal cancer after a surgical resection. The survey format included 19 questions on the principles of defining field margins, and was sent to the radiation oncologists in charge of gastrointestinal malignancies in all korean hospitals (48 hospitals). Thirty three ($69\%$) oncologists replied. On the basis of the replies and literature review, the committee developed guidelines for the optimal radiation fields nor rectal cancer Results: The following guidelines were developed: superior border between the lower tip on the L5 vertebral body and upper sacroiliac joint; inferior border $2\~3$ cm distal to the anastomosis in patient whose sphincter was saved, and $2\~3$ cm distal to the perineal scar In patients whose anal sphincter was sacrificed; anterior margin at the posterior lip of the symphysis pubis or $2\~3$ cm anterior to the vertebral body, to include the internal iliac lymph node and posterior margin $1.5\~2$ cm posterior to the anterior surface of the surface, to include the presacral space with enough margin. Comparison with the guidelines, the replies on the superior margin coincided in 23 cases ($70\%$), the inferior margin after sphincter saving surgery in 13 ($39\%$), the inferior margin after adbominoperineal resection in 32 ($97\%$), the lateral margin in 32 ($97\%$), the posterior margins in 32 ($97\%$) and the anterior margin in 16 ($45\%$). Conclusion: These recommendations should be tailored to each patient according to the clinical characteristics such as tumor location, pathological and operative findings, for the optimal treatment. The adequacy of these guidelines should be proved be following the Korean Patterns of Care Study.

키워드

참고문헌

  1. Martenson JA, Gunderson LL. Colon and Rectum.In: Perez CA, Brady LW,eds.Principles andPractice ofRadiationOncology. 3rd ed. Philadelphia PA: Lippincott Williams & Wilkins. 1997:1495-1497
  2. Skibber JM, Hoff PM, MinskyBD. Cancer of the Rectum. In: Devita VT,HellmanS, Rosenberg SA,eds.Cancer:Principles & Practice of Oncology. 6th ed. Philadelphia PA: Lippincott Williams & Wilkins. 2001:1271-1319
  3. Enker WE, MartzJ,TepperJE,RyanDP,MayerR. Rectal cancer: Management of locoregionaldisease.In:KelsenDP,DalyJM, Kern SE,Levin B,TepperJE,eds.Gastro intestinal oncology: Principles and practice. Philadelphia PA: Lippincott Williams & Wilkins. 2002:815
  4. MinskyBD. Pelvic radiation therapy in rectal cancer:Technical considerations. Semin Radiat Oncol 1993;3:42-47 https://doi.org/10.1016/S1053-4296(05)80076-1
  5. KimJH,KimDY,KimYH,etal. Surveyonradiotherapy protocols fortherectalcancersamongtheKoreanradiationoncologists in 2002 for the development of thePatterns of Care Study of radiation therapy. J Korean Soc Ther Radiol 2003; 21(1):44-53
  6. Gunderson LL, Sosin H. Areas of failure found atreoperation (second or symptomatic look) following “curativesurgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974;34(4):1278- 1292 https://doi.org/10.1002/1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO;2-F
  7. Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence followingdefinitive resections of rectal cancer. Cancer 1984;53(6):1354-1362 https://doi.org/10.1002/1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO;2-J
  8. Mendenhall WM, Million RR, Pfaff WW. Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1983;9(7):977-985 https://doi.org/10.1016/0360-3016(83)90384-X
  9. Wibe A, MollerB,NorsteinJ,etal. Anationalstrategic change intreatmentpolicyforrectalcancer-implementationof total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857-866 https://doi.org/10.1007/s10350-004-6317-7
  10. MyersonRJ,MohiuddenM,RichTA. Rectal Cancer. In: Gunderson LL,Tepper JE,eds.Clinical Radiation Oncology.Philadelphia PA: Churchill Livingston. 2000:740-743
  11. Gastrointestinal Tumor Study Group. Prolongation of the disease- freeintervalinsurgicallytreated rectal carcinoma. N Engl J Med 1985;312(23):1465-1472 https://doi.org/10.1056/NEJM198506063122301
  12. FisherB,WolmarkM,RocketteH,etal. Postoperative adjuvant chemotherapy orradiation therapy forrectalcancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80(1):21-29 https://doi.org/10.1093/jnci/80.1.21
  13. Krook JE, Moertel CG, Gunderson LL, etal. Effective surgical adjuvanttherapy for high-risk rectal carcinoma. N E n g l J M e d 1991;324(11):709-715
  14. Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992;10(4):549-557 https://doi.org/10.1200/JCO.1992.10.4.549
  15. O'ConnellMJ,MartensonJA,WieandHS,etal. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331(8):502-507 https://doi.org/10.1056/NEJM199408253310803
  16. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiationtherapyforrectal cancer: initial results of intergroup 0114. J Clin Oncol 1997;15(5):2030-2039 https://doi.org/10.1200/JCO.1997.15.5.2030
  17. Tepper JE, O'Connell M, Niedzwiecki D, et al. Adjuvanttherapy in rectal cancer: analysis of stage, sex, and local control-final report of intergroup 0114. J Clin Oncol 2002;20(7):1744-1750 https://doi.org/10.1200/JCO.2002.07.132
  18. Womark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of therectum: National Surgical Adjuvant BreastandBowelProjectProtocolR-02.J Natl Cancer Inst 2000;92(5):388-396 https://doi.org/10.1093/jnci/92.5.388
  19. SanfilippoNJ,CraneCH,SkibberJ,etal. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 2001;51(1): 176-183 https://doi.org/10.1016/S0360-3016(01)01610-8
  20. Park SW, Ahn YC, Huh SJ, et al. Individualized determination of lower margin in pelvic radiation field after low anterior resection for rectal cancer resulted in equivalent local control and radiation volume reduction compared with traditional method. J Korean Soc Ther Radiol Oncol 2000;18(3):194-199
  21. KimYS,KimJH,ChoiEK,etal. Optimalschemeofpostoperative chemoradiotherapy in rectal cancer: phase III prospective randomized trial. J Korean Soc Ther Radiol Oncol 2002;20:53-61